NCT07775534 Tear Fluid for the Detection of Tumor-associated Extracellular Vesicles in Glioblastoma Patients Status NOT_YET_RECRUITING Phase NA
NCT07758062 Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype Glioblastoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07735819 Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma Status NOT_YET_RECRUITING Phase PHASE2
NCT07731555 Characterization of the Blood-Brain Barrier in High-Grade Glioma Through Immunohistochemical, Transcriptional, Fluorescein and Radiological Analyses Status RECRUITING Phase NA
NCT07715097 Survivin-Targeted Dendritic Cell (DC) Cell Injection for Newly Diagnosed Glioblastoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07689721 ctDNA-Guided Intraventricular Therapy for CNS Malignancies Status NOT_YET_RECRUITING Phase NA
NCT07678138 Exploratory Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Tumor Neoantigen-pulsed Autologous Dendritic Cell Injection (YS247, Beijing YSCell Biotech Co., Ltd. [Abbreviated as YS])in Patients With Recurrent or Progressive Glioblastoma Status NOT_YET_RECRUITING Phase NA
NCT07674095 Assessment of a Large US EHR Database as Meeting FDA Fit-for-Purpose Requirements to Provide External Controls for Study BPM31510 in Participants With Glioblastoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07670026 Intensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression Status RECRUITING Phase PHASE2
NCT07668869 TTFields Plus FET-PET-Guided Stereotactic Radiosurgery Versus TTFields Alone for Recurrent Glioblastoma (Tarrget 2.0) Status RECRUITING Phase NA
NCT07664579 Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer Status RECRUITING Phase N/A
NCT07651020 The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors Status COMPLETED Phase N/A
NCT07636200 The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer Status RECRUITING Phase NA
NCT07634575 Triggered Imaging in Glioblastoma Based on Clinical Outcome Evaluation Compared to Routine: a Feasibility Study Status ENROLLING_BY_INVITATION Phase NA
NCT07628257 Cerebral Connectivity and Metabolic Phenotype of Gliomas: Prospective Addition of DTI and Rs-fMRI to a Preoperative FDG PET Strategy, With Neuropsychological Correlates and Post-treatment Follow-up Status NOT_YET_RECRUITING Phase NA
NCT07620548 Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas Status NOT_YET_RECRUITING Phase PHASE2
NCT07604285 A Phase 1/2 Study of Safety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated Glioblastoma Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07568782 Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers. Status NOT_YET_RECRUITING Phase N/A
NCT07560865 First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma Status RECRUITING Phase PHASE1